Vanguard Group’s Cymabay Therapeutics CBAY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-6,306,149
| Closed | -$149M | – | 4500 |
|
|
2023
Q4 | $149M | Buy |
6,306,149
+558,562
| +10% | +$13.2M | ﹤0.01% | 1660 |
|
|
2023
Q3 | $85.7M | Buy |
5,747,587
+598,707
| +12% | +$8.93M | ﹤0.01% | 1886 |
|
|
2023
Q2 | $56.4M | Buy |
5,148,880
+699,272
| +16% | +$7.66M | ﹤0.01% | 2132 |
|
|
2023
Q1 | $38.8M | Buy |
4,449,608
+774,310
| +21% | +$6.75M | ﹤0.01% | 2290 |
|
|
2022
Q4 | $23M | Buy |
3,675,298
+10,236
| +0.3% | +$64.2K | ﹤0.01% | 2553 |
|
|
2022
Q3 | $12.8M | Buy |
3,665,062
+108,020
| +3% | +$378K | ﹤0.01% | 2830 |
|
|
2022
Q2 | $10.5M | Sell |
3,557,042
-285,334
| -7% | -$842K | ﹤0.01% | 2968 |
|
|
2022
Q1 | $12M | Buy |
3,842,376
+53,919
| +1% | +$168K | ﹤0.01% | 3055 |
|
|
2021
Q4 | $12.8M | Buy |
3,788,457
+443,149
| +13% | +$1.5M | ﹤0.01% | 3089 |
|
|
2021
Q3 | $12.2M | Buy |
3,345,308
+18,526
| +0.6% | +$67.6K | ﹤0.01% | 3132 |
|
|
2021
Q2 | $14.5M | Sell |
3,326,782
-367,636
| -10% | -$1.6M | ﹤0.01% | 3014 |
|
|
2021
Q1 | $16.8M | Buy |
3,694,418
+267,407
| +8% | +$1.21M | ﹤0.01% | 2876 |
|
|
2020
Q4 | $19.7M | Buy |
3,427,011
+53,892
| +2% | +$309K | ﹤0.01% | 2641 |
|
|
2020
Q3 | $24.4M | Sell |
3,373,119
-7,631
| -0.2% | -$55.3K | ﹤0.01% | 2355 |
|
|
2020
Q2 | $11.8M | Sell |
3,380,750
-309,090
| -8% | -$1.08M | ﹤0.01% | 2682 |
|
|
2020
Q1 | $5.46M | Sell |
3,689,840
-1,485
| -0% | -$2.2K | ﹤0.01% | 2941 |
|
|
2019
Q4 | $7.24M | Buy |
3,691,325
+13,931
| +0.4% | +$27.3K | ﹤0.01% | 3010 |
|
|
2019
Q3 | $18.8M | Buy |
3,677,394
+117,519
| +3% | +$602K | ﹤0.01% | 2517 |
|
|
2019
Q2 | $25.5M | Buy |
3,559,875
+226,906
| +7% | +$1.62M | ﹤0.01% | 2391 |
|
|
2019
Q1 | $44.3M | Buy |
3,332,969
+397,479
| +14% | +$5.28M | ﹤0.01% | 2152 |
|
|
2018
Q4 | $23.1M | Buy |
2,935,490
+146,302
| +5% | +$1.15M | ﹤0.01% | 2386 |
|
|
2018
Q3 | $30.9M | Buy |
2,789,188
+109,989
| +4% | +$1.22M | ﹤0.01% | 2371 |
|
|
2018
Q2 | $36M | Buy |
2,679,199
+140,285
| +6% | +$1.88M | ﹤0.01% | 2299 |
|
|
2018
Q1 | $33M | Buy |
2,538,914
+759,607
| +43% | +$9.87M | ﹤0.01% | 2289 |
|
|
2017
Q4 | $16.4M | Buy |
1,779,307
+238,105
| +15% | +$2.19M | ﹤0.01% | 2580 |
|
|
2017
Q3 | $12.4M | Buy |
1,541,202
+549,569
| +55% | +$4.43M | ﹤0.01% | 2709 |
|
|
2017
Q2 | $5.71M | Buy |
991,633
+170,126
| +21% | +$980K | ﹤0.01% | 3038 |
|
|
2017
Q1 | $3.53M | Buy |
821,507
+293,823
| +56% | +$1.26M | ﹤0.01% | 3191 |
|
|
2016
Q4 | $913K | Sell |
527,684
-87,021
| -14% | -$151K | ﹤0.01% | 3586 |
|
|
2016
Q3 | $1.19M | Buy |
614,705
+2,456
| +0.4% | +$4.76K | ﹤0.01% | 3535 |
|
|
2016
Q2 | $1.07M | Buy |
612,249
+62,896
| +11% | +$109K | ﹤0.01% | 3592 |
|
|
2016
Q1 | $742K | Buy |
549,353
+50,627
| +10% | +$68.4K | ﹤0.01% | 3679 |
|
|
2015
Q4 | $843K | Buy |
498,726
+70,819
| +17% | +$120K | ﹤0.01% | 3676 |
|
|
2015
Q3 | $830K | Buy |
427,907
+95,600
| +29% | +$185K | ﹤0.01% | 3690 |
|
|
2015
Q2 | $894K | Buy |
332,307
+14,260
| +4% | +$38.4K | ﹤0.01% | 3690 |
|
|
2015
Q1 | $2.2M | Buy |
318,047
+32,200
| +11% | +$223K | ﹤0.01% | 3366 |
|
|
2014
Q4 | $2.81M | Buy |
285,847
+3,400
| +1% | +$33.4K | ﹤0.01% | 3155 |
|
|
2014
Q3 | $1.93M | Buy |
+282,447
| New | +$1.93M | ﹤0.01% | 3278 |
|